Clinical progress in MSC-based therapies for the management of severe COVID-19

Considering the high impact that severe Coronavirus disease 2019 (COVID-19) cases still pose on public health and their complex pharmacological management, the search for new therapeutic alternatives is essential. Mesenchymal stromal cells (MSCs) could be promising candidates as they present importa...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossello-Gelabert, Maria, Gonzalez-Pujana, Ainhoa, Igartua, Manoli, Santos-Vizcaino, Edorta, Hernandez, Rosa Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259053/
https://www.ncbi.nlm.nih.gov/pubmed/35843774
http://dx.doi.org/10.1016/j.cytogfr.2022.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259053/
https://www.ncbi.nlm.nih.gov/pubmed/35843774
http://dx.doi.org/10.1016/j.cytogfr.2022.07.002

Ejemplares similares